Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections
…, AI Cubas-Atienzar, LE Cuevas, M Cusinato… - MedRxiv, 2020 - medrxiv.org
We report dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …
[HTML][HTML] IgG seroconversion and pathophysiology in severe acute respiratory syndrome coronavirus 2 infection
…, LE Cuevas, M Cusinato… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated the dynamics of seroconversion in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …
Increased monocyte distribution width in COVID‐19 and sepsis arises from a complex interplay of altered monocyte cellular size and subset frequency
M Cusinato, L Hadcocks, S Yona… - International Journal …, 2022 - Wiley Online Library
Introduction Monocyte distribution width (MDW), a parameter generated alongside full blood
counts (FBC) in new‐generation haematology analysers, has been proposed as a …
counts (FBC) in new‐generation haematology analysers, has been proposed as a …
Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration
…, AI Cubas-Atienzar, LE Cuevas, M Cusinato… - MedRxiv, 2020 - medrxiv.org
Here we describe an open and transparent consortium for the rapid development of COVID-19
rapid diagnostics tests. We report diagnostic accuracy data on the Mologic manufactured …
rapid diagnostics tests. We report diagnostic accuracy data on the Mologic manufactured …
[HTML][HTML] Increased risk of death in COVID-19 hospital admissions during the second wave as compared to the first epidemic wave: a prospective, single-centre cohort …
M Cusinato, J Gates, D Jajbhay, T Planche, YE Ong - Infection, 2022 - Springer
Background The second coronavirus disease (COVID-19) epidemic wave in the UK
progressed aggressively and was characterised by the emergence and circulation of variant of …
progressed aggressively and was characterised by the emergence and circulation of variant of …
[HTML][HTML] The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study
…, C Logan, A Mazzella, RM Wake, M Cusinato… - BMC Infectious …, 2023 - Springer
Background Immunosuppressive therapies have become a cornerstone of the management
of severe COVID-19. The impact of these therapies on secondary infections and …
of severe COVID-19. The impact of these therapies on secondary infections and …
[HTML][HTML] Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia
AW Tadesse, M Cusinato, GT Weldemichael… - BMC public health, 2023 - Springer
Background Non-adherence to tuberculosis treatment increases the risk of poor treatment
outcomes. Digital adherence technologies (DATs), including the smart pillbox (EvriMED), aim …
outcomes. Digital adherence technologies (DATs), including the smart pillbox (EvriMED), aim …
[HTML][HTML] Sensitivity and specificity of monocyte distribution width (MDW) in detecting patients with infection and sepsis in patients on sepsis pathway in the emergency …
M Cusinato, N Sivayoham, T Planche - Infection, 2023 - Springer
Purpose Monocyte distribution width (MDW) is a biomarker for the early identification of sepsis.
We assessed its accuracy in patients presenting with suspected sepsis in the emergency …
We assessed its accuracy in patients presenting with suspected sepsis in the emergency …
Clostridioides (Clostridium) difficile
T Planche, M Cusinato - Medicine, 2021 - Elsevier
Clostridioides difficile (formerly Clostridium) causes a potentially life-threatening diarrhoea,
which is acquired predominantly in hospitals. The incidence of infections caused by this …
which is acquired predominantly in hospitals. The incidence of infections caused by this …
Quality of Life Outcomes in Participants of a Randomised Controlled Clinical Trial for Rifampicin Resistant Tuberculosis (The PRACTECAL-PRO Study)
M Cusinato, K Lowton, B Stringer, K Fielding… - Available at SSRN … - papers.ssrn.com
Background/Introduction: TB-PRACTECAL studied six-month, more tolerable regimens of oral
drugs for rifampicin resistant tuberculosis. The PRACTECAL-PRO, a sub study, measured …
drugs for rifampicin resistant tuberculosis. The PRACTECAL-PRO, a sub study, measured …
